Clinical Trial Update: The Sagittarius Trial [Phase 3]

View source ↗

Summary

The Sagittarius trial is a Phase 3 study sponsored by IFOM ETS - The AIRC Institute of Molecular Oncology and is currently recruiting for colon cancer Stage II …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: IFOM ETS - The AIRC Institute of Molecular Oncology | Conditions: Colon Cancer Stage II, Colon Cancer Stage III | Phase 3 | Status: RECRUITING